Investing.com - Sartorius Stedim reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Sartorius Stedim announced earnings per share of €2.21 on revenue of €862.5M. Analysts polled by Investing.com anticipated EPS of €3.63 on revenue of €774.67M.
Sartorius Stedim shares are down 25% from the beginning of the year and are trading at €357.50 , down-from-52-week-high.They are under-performing the STOXX 600 which is down 5.22% from the start of the year.
Sartorius Stedim shares gained 4.53% in intra-day trade the report.
Sartorius Stedim follows other major Healthcare sector earnings this month
Sartorius Stedim's report follows an earnings missed by Valneva on March 24, who reported EPS of €0.61 on revenue of €278.3M (NYSE:MMM), compared to forecasts EPS of €0.92 on revenue of €152.55M.
Innate Pharma had beat expectations on March 24 with first quarter EPS of €-0.27 on revenue of €3.81M, compared to forecast for EPS of €-0.32 on revenue of €14.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar